Archives

YY Group (NASDAQ: YYGH) Unveils Scalable AI Training Data Strategy to Power Next-Generation Robotics and Artificial Intelligence

B Leverages a 500,000-user workforce network across 12 countries to generate structured real-world AI training datasets Unlocks high-margin, data-driven revenue opportunities and global technology partnerships… Login to continue reading Login…

Read MoreYY Group (NASDAQ: YYGH) Unveils Scalable AI Training Data Strategy to Power Next-Generation Robotics and Artificial Intelligence

Ada Health Clinical AI Turns Symptom Uncertainty Into Appropriate Action, Finds NEJM AI Study Conducted with CUF in Portugal

B Real-world study at CUF, Portugal’s largest private healthcare network: Ada’s accurate, medical-grade assessment changed the behavior of 3 in 5 patients — and more… Login to continue reading Login…

Read MoreAda Health Clinical AI Turns Symptom Uncertainty Into Appropriate Action, Finds NEJM AI Study Conducted with CUF in Portugal

Amperos Health Secures $16M Investment as it Launches Industry’s First AI-Native Denial Management and Revenue Recovery Platform

B Helping providers resolve denials five times faster and cut denial rates by 70% NEW YORK, April 22, 2026 /PRNewswire/ — Amperos Health, the first… Login to continue reading Login…

Read MoreAmperos Health Secures $16M Investment as it Launches Industry’s First AI-Native Denial Management and Revenue Recovery Platform

IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)

B Through 120 weeks of follow-up, IMAAVY delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+ and anti-MuSK+ Patients… Login to continue reading Login…

Read MoreIMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)